LENSAR (NASDAQ:LNSR) Shares Up 1% – Should You Buy?

Shares of LENSAR, Inc. (NASDAQ:LNSR) traded up 1% during trading on Thursday . The stock traded as high as $11.99 and last traded at $11.99. 23,354 shares traded hands during mid-day trading, a decline of 31% from the average session volume of 33,894 shares. The stock had previously closed at $11.87.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on LNSR shares. Wall Street Zen upgraded shares of LENSAR to a “hold” rating in a report on Friday, November 28th. Weiss Ratings restated a “sell (d-)” rating on shares of LENSAR in a research note on Wednesday, October 8th. Two investment analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, LENSAR presently has a consensus rating of “Reduce” and an average target price of $15.00.

LENSAR Stock Up 1.0%

The firm has a market cap of $143.16 million, a P/E ratio of -2.73 and a beta of 0.70. The firm’s 50-day simple moving average is $11.10 and its 200 day simple moving average is $12.02.

LENSAR (NASDAQ:LNSR) last issued its quarterly earnings results on Thursday, November 6th. The company reported ($0.31) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.08) by ($0.23). The firm had revenue of $14.32 million for the quarter, compared to the consensus estimate of $17.75 million.

Institutional Investors Weigh In On LENSAR

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Groupe la Francaise lifted its holdings in LENSAR by 99.5% during the second quarter. Groupe la Francaise now owns 251,400 shares of the company’s stock valued at $3,311,000 after purchasing an additional 125,400 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of LENSAR by 103.9% during the 2nd quarter. Geode Capital Management LLC now owns 219,373 shares of the company’s stock valued at $2,890,000 after buying an additional 111,802 shares in the last quarter. Credit Industriel ET Commercial boosted its holdings in LENSAR by 98.4% in the 2nd quarter. Credit Industriel ET Commercial now owns 168,600 shares of the company’s stock worth $2,220,000 after buying an additional 83,600 shares during the period. Skandinaviska Enskilda Banken AB publ bought a new position in LENSAR in the 2nd quarter worth approximately $756,000. Finally, Rangeley Capital LLC purchased a new position in LENSAR in the 2nd quarter valued at approximately $658,000. 40.15% of the stock is currently owned by institutional investors.

LENSAR Company Profile

LENSAR, Inc, headquartered in Orlando, Florida, is a medical technology company specializing in advanced laser systems for ophthalmic surgery. Its flagship product, the LENSAR Laser System, combines proprietary three-dimensional imaging with precision-guided femtosecond laser delivery to perform critical steps in cataract procedures, including capsulotomy creation, lens fragmentation and corneal incisions.

Founded in 2005, LENSAR has concentrated its research and development efforts on enhancing surgical accuracy and patient outcomes in cataract treatment.